Stock 300497 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangxi Fushine Pharmaceutical Co., Ltd.

Equities

300497

CNE1000024Z7

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-05 EDT 		5-day change 1st Jan Change
11.59 CNY +2.57% Intraday chart for Jiangxi Fushine Pharmaceutical Co., Ltd. +15.90% +23.82%
04-28 Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-28 Jiangxi Fushine Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Jiangxi Fushine Pharmaceutical Co., Ltd. is principally engaged in research and development, manufacturing and sales of bulk drugs, pharmaceutical intermediates and related products. The Company's main products include sulbactam series enzyme inhibitor bulk drugs, pharmaceutical intermediates and related products, tazobactam series enzyme inhibitor bulk drugs, pharmaceutical intermediates and related products, as well as intermediates of carbapenems bulk drugs. The Company distributes its products within domestic markets and to overseas markets, including European Union (EU) and other countries and regions in Asia.

Number of employees: 2,179

Sales per Business

CNY in Million2021Weight2022Weight Delta
Pharmaceutical
100.0 %
1,430 100.0 % 1,647 100.0 % +15.23%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
63.5 %
740 51.7 % 1,045 63.5 % +41.29%
Foreign
36.5 %
690 48.3 % 602 36.5 % -12.72%

Managers

Managers TitleAgeSince
Jian Hua Bao CEO
 Chief Executive Officer 47 12-07-31
Guang Yang DFI
 Director of Finance/CFO 37 08-12-31
Rong Wu Cheng BRD
 Director/Board Member 55 04-04-30
Ying Liu PRN
 Corporate Officer/Principal 43 22-04-12
Peng Yun SEC
 Corporate Secretary 32 22-04-12

Members of the board

Members of the board TitleAgeSince
Yan Li BRD
 Director/Board Member 67 15-06-30
Jian Hua Bao CEO
 Chief Executive Officer 47 12-07-31
Wei Dong BRD
 Director/Board Member 46 12-07-31
Wen Yu BRD
 Director/Board Member 62 12-07-31
Hong Liu BRD
 Director/Board Member 63 21-07-31
Hai Bin Yang CHM
 Chairman 51 12-07-31
Rong Wu Cheng BRD
 Director/Board Member 55 04-04-30
Dan Ke BRD
 Director/Board Member 48 07-12-31
Xiang Qiang Chen BRD
 Director/Board Member 45 22-04-12
Ting Ye BRD
 Director/Board Member 39 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 550,004,834 389,197,241 ( 70.76 %) 11,355,900 ( 2.065 %) 70.76 %

Shareholders

NameEquities%Valuation
Jian Hua Bao
7.028 %
31,439,152 7.028 % 40 M ¥
Yuan Song Wang
4.782 %
21,391,800 4.782 % 28 M ¥
JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.
2.539 %
11,355,900 2.539 % 15 M ¥
Jingdezhen State Owned Assets Sup & Admin Commission
1.494 %
6,683,652 1.494 % 9 M ¥
Jiangxi Fushine Pharmaceutical Co. Ltd. ESOP
1.137 %
5,085,144 1.137 % 7 M ¥
Bing Deng
1.006 %
4,500,000 1.006 % 6 M ¥
Wen Yu
0.9849 %
4,405,462 0.9849 % 6 M ¥
Jing Jing Wu
0.7221 %
3,230,000 0.7221 % 4 M ¥
Gongqingcheng Yunfeng Asset Management Co. Ltd.
0.6219 %
2,781,880 0.6219 % 4 M ¥
Purple Rice Shanghai Asset Management Co. Ltd.
0.5566 %
2,489,900 0.5566 % 3 M ¥
NameEquities%Valuation
Jian Hua Bao
83.85 %
86,111,856 83.85 % 111 M ¥
Wen Yu
12.87 %
13,216,384 12.87 % 17 M ¥
Dan Ke
2.573 %
2,642,250 2.573 % 3 M ¥

Holdings

NameEquities%Valuation
JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.
2.54%
 11,355,900 2.54% 14,627,989 $

Company contact information

Jiangxi Fushine Pharmaceutical Co., Ltd.

Junction of Yushan & Liyang No. 2 Yuli Industrial Zone

333000, Jingdezhen

+86 79 8269 9929

http://www.fushine.cn
address Jiangxi Fushine Pharmaceutical Co., Ltd.(300497)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANGXI FUSHINE PHARMACEUTICAL CO., LTD. Stock Jiangxi Fushine Pharmaceutical Co., Ltd.
+23.82% 841M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+31.52% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.96% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.21% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.02% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.01% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.81% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-10.63% 194B
AMGEN INC. Stock Amgen Inc.
+3.98% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300497 Stock
  4. Company Jiangxi Fushine Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW